应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
已收盘 02-10 16:09:14
4.690
+0.010
+0.21%
最高
4.710
最低
4.640
成交量
1,319万
今开
4.690
昨收
4.680
日振幅
1.50%
总市值
294.67亿
流通市值
294.65亿
总股本
62.83亿
成交额
6,185万
换手率
0.21%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华润医药集团投资建设健康消费品产业园
美股速递 · 18:09
华润医药集团投资建设健康消费品产业园
华润医药(03320):东阿阿胶(000423.SZ)拟投资及建设健康消费品产业园
智通财经 · 18:09
华润医药(03320):东阿阿胶(000423.SZ)拟投资及建设健康消费品产业园
华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划
美股速递 · 02-09 19:47
华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划
华润医药(03320)潜在出售天麦生物科技约17.87 %股权
智通财经 · 02-09 19:47
华润医药(03320)潜在出售天麦生物科技约17.87 %股权
华润医药通过上海联合产权交易所公开挂牌处置资产
美股速递 · 02-09 19:46
华润医药通过上海联合产权交易所公开挂牌处置资产
博雅生物:在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业
证券之星 · 02-09 17:18
博雅生物:在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业
每日卖空追踪 | 华润医药 02月09日卖空量成交110.65万股,卖空比例为6.42%
市场透视 · 02-09 16:30
每日卖空追踪 | 华润医药 02月09日卖空量成交110.65万股,卖空比例为6.42%
华润医药02月09日主力净流入585.0万元 散户资金抛售
市场透视 · 02-09 16:15
华润医药02月09日主力净流入585.0万元 散户资金抛售
华润医药完善公司治理机制,明确股东大会与董事会权责
金吾财讯 · 02-06
华润医药完善公司治理机制,明确股东大会与董事会权责
昆药集团(3320.HK)公布2025年度初步财务数据,营收与利润同比大幅下降。
金吾财讯 · 02-06
昆药集团(3320.HK)公布2025年度初步财务数据,营收与利润同比大幅下降。
华润三九2025年度财报出炉,营业总收入同比增长14.53%
金吾财讯 · 02-06
华润三九2025年度财报出炉,营业总收入同比增长14.53%
华润三九2025年营收316.29亿元,经调整净利润31.56亿元
公告速递 · 02-06
华润三九2025年营收316.29亿元,经调整净利润31.56亿元
华润医药(03320):天士力医药2025年度归母净利润11.05亿元,同比增长15.68%
智通财经 · 02-06
华润医药(03320):天士力医药2025年度归母净利润11.05亿元,同比增长15.68%
天士力医药2025财年营收82.36亿元,经调整净利润7.87亿元
公告速递 · 02-06
天士力医药2025财年营收82.36亿元,经调整净利润7.87亿元
昆药集团2025年度营收65.77亿元,经调整净利润10.71亿元
公告速递 · 02-06
昆药集团2025年度营收65.77亿元,经调整净利润10.71亿元
华润医药旗下昆药集团全年初步归属股东净利润达3.499亿元
美股速递 · 02-06
华润医药旗下昆药集团全年初步归属股东净利润达3.499亿元
每日卖空追踪 | 华润医药 02月06日卖空量成交98.7万股,卖空比例为10.92%
市场透视 · 02-06
每日卖空追踪 | 华润医药 02月06日卖空量成交98.7万股,卖空比例为10.92%
每日卖空追踪 | 华润医药 02月05日卖空量成交38.45万股,卖空比例为4.36%
市场透视 · 02-05
每日卖空追踪 | 华润医药 02月05日卖空量成交38.45万股,卖空比例为4.36%
25个独家中成药颗粒剂火了!潜力品种飙涨183%,华润三九、步长亮眼,49款中药新药全速推进
米内网 · 02-05
25个独家中成药颗粒剂火了!潜力品种飙涨183%,华润三九、步长亮眼,49款中药新药全速推进
华润医药02月05日获主力加仓359.1万元
市场透视 · 02-05
华润医药02月05日获主力加仓359.1万元
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.69,"timestamp":1770710954005,"preClose":4.68,"halted":0,"volume":13190910,"delay":0,"changeRate":0.002136752136752281,"floatShares":6282510461,"shares":6283000000,"eps":0.530245,"marketStatus":"已收盘","change":0.01,"latestTime":"02-10 16:09:14","open":4.69,"high":4.71,"low":4.64,"amount":61850224,"amplitude":0.014957,"askPrice":4.7,"askSize":179500,"bidPrice":4.69,"bidSize":28000,"shortable":3,"etf":0,"ttmEps":0.488332,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":5,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.68,"dividendRate":0.028794,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"volumeRatio":1.267613,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320/wiki","defaultTab":"wiki","newsList":[{"id":"1117458768","title":"华润医药集团投资建设健康消费品产业园","url":"https://stock-news.laohu8.com/highlight/detail?id=1117458768","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117458768?lang=zh_cn&edition=full","pubTime":"2026-02-10 18:09","pubTimestamp":1770718182,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司宣布,将投资兴建健康消费品产业园项目。该举措旨在拓展公司在健康消费领域的产业布局,提升产品研发与生产能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2610670645","title":"华润医药(03320):东阿阿胶(000423.SZ)拟投资及建设健康消费品产业园","url":"https://stock-news.laohu8.com/highlight/detail?id=2610670645","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610670645?lang=zh_cn&edition=full","pubTime":"2026-02-10 18:09","pubTimestamp":1770718149,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药 公布,公司非全资附属公司东阿阿胶议决投资及建设健康消费品产业园。拟议项目亦符合东阿阿胶健康消费品业务发展的迫切需要。此外,自建厂房有助于构建东阿阿胶健康消费品领域核心优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000423","BK1191","BK0010","BK0175","BK0188","BK0028","BK1570","BK0196","BK0183","BK0239","SG9999014674.SGD","03320","BK0187"],"gpt_icon":0},{"id":"1139668716","title":"华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1139668716","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139668716?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:47","pubTimestamp":1770637648,"startTime":"0","endTime":"0","summary":"华润医药旗下关联单位已着手启动一项潜在交易,拟处置其持有的合肥天麦生物科技发展有限公司17.87%的股权。此次股权变动可能涉及重大资产重组,目前相关方案尚在初步筹划阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2610321176","title":"华润医药(03320)潜在出售天麦生物科技约17.87 %股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2610321176","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610321176?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:47","pubTimestamp":1770637624,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,本公司全资附属公司华润医药投资有限公司(华润医药投资)已启动潜在出售华润医药投资及其附属公司所持有合肥天麦生物科技发展有限公司(天麦生物科技)的约17.87 %股权(潜在出售事项),其将通过上海联合产权交易所进行公开挂牌,挂牌底价约为人民币14.2亿元。于本公告日期,华润医药投资及其附属公司持有天麦生物科技少于30 %股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LABU","BK1570","BK4585","BK4588","03320","159837","BK1191"],"gpt_icon":0},{"id":"1143808481","title":"华润医药通过上海联合产权交易所公开挂牌处置资产","url":"https://stock-news.laohu8.com/highlight/detail?id=1143808481","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143808481?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:46","pubTimestamp":1770637574,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司(股票代码:03320)宣布,将采用公开挂牌方式,在上海联合产权交易所对其部分资产进行处置。这一举措旨在优化公司资产结构,提升资源配置效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2610164633","title":"博雅生物:在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610164633","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610164633?lang=zh_cn&edition=full","pubTime":"2026-02-09 17:18","pubTimestamp":1770628696,"startTime":"0","endTime":"0","summary":"证券之星消息,博雅生物02月09日在投资者关系平台上答复投资者关心的问题。华润集团成为公司实际控制人后,在新浆站申请、资源嫁接、浆站运营等方面给予大力支持。在华润集团及华润医药等股东的支持下,公司将继续致力于成为世界一流的血液制品企业,不断推动行业健康发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020900021764.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK0197","BK0046","300294","03320","BK1570"],"gpt_icon":0},{"id":"2610650785","title":"每日卖空追踪 | 华润医药 02月09日卖空量成交110.65万股,卖空比例为6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610650785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610650785?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625834,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月09日,涨2.63%,卖空量成交110.65万股,较上一交易日减少28.17%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163938a6e55208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163938a6e55208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2610502786","title":"华润医药02月09日主力净流入585.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610502786?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624939,"startTime":"0","endTime":"0","summary":"02月09日, 华润医药股价涨2.63%,报收4.68元,成交金额8208.4万元,换手率0.28%,振幅1.75%,量比1.79。华润医药今日主力资金净流入585.0万元,上一交易日主力净流出112.4万元。该股近5个交易日上涨5.17%,主力资金累计净流入1097.8万元;近20日主力资金累计净流出713.0万元,其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162005a6e53a24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162005a6e53a24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2609519565","title":"华润医药完善公司治理机制,明确股东大会与董事会权责","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519565","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519565?lang=zh_cn&edition=full","pubTime":"2026-02-06 23:17","pubTimestamp":1770391050,"startTime":"0","endTime":"0","summary":"公告明确了股东大会的召开与参与程序,包括会议通知、出席与表决方式,以及电子会议的可行性。董事会的职责与权力也得到了详细规定。他们负责公司的日常运营,执行董事会的决策,并由董事会聘任和解聘。华润医药通过此次公告,展示了其对公司治理结构的重视与不断完善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206232622a4853bfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206232622a4853bfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2609519552","title":"昆药集团(3320.HK)公布2025年度初步财务数据,营收与利润同比大幅下降。","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519552","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519552?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:05","pubTimestamp":1770383159,"startTime":"0","endTime":"0","summary":")金吾财讯|昆药集团于2026年2月6日公布了其截至2025年12月31日止年度的未经审核初步财务数据。总体来看,昆药集团在2025年的营收与利润均出现了大幅下降,主要受到中成药集中采购进度不及预期、医保费用管控政策持续深化等多重因素的影响。具体而言,昆药集团2025年度实现营业总收入为人民币657,666.41万元,同比下滑21.72%;营业利润为人民币44,850.80万元,同比下滑51.65%;利润总额为人民币47,355.78万元,同比下滑49.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206214255a6dbdfd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206214255a6dbdfd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2609519516","title":"华润三九2025年度财报出炉,营业总收入同比增长14.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519516","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519516?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:41","pubTimestamp":1770381675,"startTime":"0","endTime":"0","summary":"金吾财讯|华润三九于2026年2月6日公布了其截至2025年12月31日止年度的未经审核初步财务资料。财报显示,公司在2025年实现营业总收入人民币316.29亿元,同比增长14.53%;营业利润为人民币48.48亿元,同比增长8.34%;利润总额为人民币48.60亿元,同比增长5.81%。归属于上市公司股东的净利润为人民币34.22亿元,同比增长1.60%。在资产方面,截至2025年底,华润三九的总资产达到人民币588.07亿元,同比增长46.72%,主要得益于报告期内对天士力医药集团股份有限公司的收购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206205321a484bf9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206205321a484bf9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"1135687062","title":"华润三九2025年营收316.29亿元,经调整净利润31.56亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135687062","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135687062?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:41","pubTimestamp":1770381671,"startTime":"0","endTime":"0","summary":"本季度信息\n华润三九公布2025年全年未经审计初步财务数据显示,报告期内营业总收入达到人民币316.29亿元(同比增长14.53%),营业利润为48.48亿元(同比增长8.34%)。扣除非经常性收益或亏损后,净利润为31.56亿元(同比增长1.23%)。\n受流感等呼吸道疾病发病率降低和医保控费持续等因素影响,公司持续聚焦核心治疗领域,不断扩充研发管线和品牌布局,业务总体保持稳健增长。总体资产规模同比增长46.72%,主要由于期内收购天士力医药集团股份有限公司。\n业务分项\n暂无拆分数据披露。\n高管解读\n暂无高管表述披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"gpt_icon":0},{"id":"2609241593","title":"华润医药(03320):天士力医药2025年度归母净利润11.05亿元,同比增长15.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609241593","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609241593?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:40","pubTimestamp":1770381648,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布天士力医药截至2025年12月31日止年度的未经审核初步财务资料,天士力医药实现总营业收入人民币82.36亿元,同比下降3.08%,实现归属于上市公司股东的净利润人民币11.05亿元,同比增长15.68%。从变动幅度上看,公司营业收入同比下降的主要原因是医药商业收入(主要为连锁药店业务)受“门诊统筹”等行业性政策的影响同比减少14.24%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600535","159938","03320","09939"],"gpt_icon":0},{"id":"1100554861","title":"天士力医药2025财年营收82.36亿元,经调整净利润7.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100554861","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100554861?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:36","pubTimestamp":1770381369,"startTime":"0","endTime":"0","summary":"本季度信息\n天士力医药发布2025财年主要财务数据(截至2025年12月31日止年度),营业总收入82.36亿元,同比下降3.08%。报告期内,经调整净利润(扣除非经常性收益或亏损后)7.87亿元,同比下降24.06%。同时,营业利润达到13.50亿元,同比增长25.51%。\n业务分项\n天士力医药在心血管及代谢、神经/精神、消化三大领域持续发力。公司提到,由于“门诊统筹”等行业性政策影响,主要包含连锁药店业务的医药商商业绩同比减少14.24%。为应对行业集採控费等外部因素,公司加快与华润三九的资源整合,注重创新驱动与“首年融合”推进,力求进一步提升企业效益与竞争力。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"gpt_icon":0},{"id":"1185937278","title":"昆药集团2025年度营收65.77亿元,经调整净利润10.71亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1185937278","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185937278?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:06","pubTimestamp":1770379593,"startTime":"0","endTime":"0","summary":"根据昆药集团公布的截至2025年12月31日止年度财务数据,报告期内营收为人民币65.77亿元,同比下降21.72%。经调整净利润约为人民币10.71亿元,同比下降74.45%。报告期内非经常性收益或亏损约为人民币2.43亿元,同比上涨6.1%,主要由于关联公司的上市带动相关金融资产公允价值变动和投资收益增长;同期政府补助约为人民币0.70亿元,同比下降24.15%。上述多重因素叠加,使得经调整净利润降幅进一步扩大。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"gpt_icon":0},{"id":"1155665228","title":"华润医药旗下昆药集团全年初步归属股东净利润达3.499亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1155665228","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155665228?lang=zh_cn&edition=full","pubTime":"2026-02-06 20:05","pubTimestamp":1770379542,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司(股票代码:03320)近日披露,其控股子公司昆药集团股份有限公司(股票代码:600422)公布的全年初步财务数据显示,报告期内归属于上市公司股东的净利润为3.499亿元人民币。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK0028","BK0060","BK1191","600422","BK1570","BK0188","BK0239"],"gpt_icon":0},{"id":"2609519593","title":"每日卖空追踪 | 华润医药 02月06日卖空量成交98.7万股,卖空比例为10.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609519593","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609519593?lang=zh_cn&edition=full","pubTime":"2026-02-06 16:30","pubTimestamp":1770366636,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月06日,涨0.22%,卖空量成交98.7万股,较上一交易日增加22.99%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163554a6dac479&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260206163554a6dac479&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2609586632","title":"每日卖空追踪 | 华润医药 02月05日卖空量成交38.45万股,卖空比例为4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609586632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609586632?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:30","pubTimestamp":1770280234,"startTime":"0","endTime":"0","summary":"华润医药北京时间02月05日,涨1.56%,卖空量成交38.45万股,较上一交易日减少60.13%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163649a6d657fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205163649a6d657fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","03320","BK1191"],"gpt_icon":0},{"id":"2609586633","title":"25个独家中成药颗粒剂火了!潜力品种飙涨183%,华润三九、步长亮眼,49款中药新药全速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2609586633","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609586633?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:25","pubTimestamp":1770279951,"startTime":"0","endTime":"0","summary":"康缘、以岭、悦康......49款中药新药全速推进。10个品牌销售额呈正增长,有7个涨幅达两位数及以上。其中,云南白药集团的参苓健脾胃颗粒飙涨182.64%,华润医药的小柴胡颗粒、康臣药业的尿毒清颗粒(无糖型)均涨超23%,华润医药的养胃舒颗粒大涨15.8%,华润医药的复方感冒灵颗粒和参苓健脾胃颗粒、浙江天皇药业的铁皮枫斗颗粒均涨逾10%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205174757a47faf1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205174757a47faf1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01681","BK1191","03320","BK1570","02877"],"gpt_icon":0},{"id":"2609858668","title":"华润医药02月05日获主力加仓359.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609858668","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609858668?lang=zh_cn&edition=full","pubTime":"2026-02-05 16:15","pubTimestamp":1770279304,"startTime":"0","endTime":"0","summary":"02月05日, 华润医药股价涨1.56%,报收4.55元,成交金额3986.2万元,换手率0.14%,振幅1.56%,量比0.91。华润医药今日主力资金净流入359.1万元,连续3日净流入,上一交易日主力净流入263.9万元。该股近5个交易日下跌1.30%,主力资金累计净流出399.9万元;近20日主力资金累计净流出1328.6万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161513a6d63d95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260205161513a6d63d95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1570","03320"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":0.0517},{"period":"1month","weight":0.0152},{"period":"3month","weight":-0.064},{"period":"6month","weight":-0.106},{"period":"1year","weight":-0.0856},{"period":"ytd","weight":0.0517}],"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0124},{"period":"6month","weight":0.0552},{"period":"1year","weight":0.2789},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案,如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.01279},{"month":2,"riseRate":0.8,"avgChangeRate":0.048241},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.026504},{"month":4,"riseRate":0.777778,"avgChangeRate":0.043844},{"month":5,"riseRate":0.555556,"avgChangeRate":0.013028},{"month":6,"riseRate":0.333333,"avgChangeRate":0.004789},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.042472},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.002095},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.020729},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.02714},{"month":11,"riseRate":0.4,"avgChangeRate":0.010225},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000929}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}